News - Perrigo


Current filters:


Popular Filters

Perrigo transfers ELND005 assets; buys OTC products


Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

Generic Temodar launches in USA


Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA) and Perrigo (NYSE: PRGO;TASE) today…

GenericsMarkets & MarketingMerck & CoNorth AmericaOncologyPerrigoTemodarTeva Pharmaceutical Industries

July a strong month for life sciences IPOs and M&A


The life sciences initial public offering (IPO) market continued to heat up in July as six life sciences…

BiotechnologyCubist PharmaceuticalsFinancialMergers & AcquisitionsPerrigoPharmaceuticalRoche

Elan board agrees $8.6 billion takeover bid


US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Tentative FDA clearance for generic copy of Novo Nordisk diabetes product


US drugmaker Perrigo (Nasdaq: PRGO; TASE) says it has received tentative approval from the US Food &…

DiabetesGenericsNorth AmericaNovo NordiskPerrigoPrandinRegulation

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million


Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Perrigo acquires UK drugmaker Rosemont for £180 million


USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition…

GenericsMergers & AcquisitionsPerrigoPharmaceuticalRosemont Pharmaceuticals

Perrigo buys full control of Cobrek Pharma for about $45 million


US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

Perrigo in patent settlement with Cadence over Ofirmev


Cadence Pharmaceuticals (Nasdaq: CADX) has entered into settlement and license agreements with fellow…

Cadence PharmaceuticalsGenericsNeurologicalNorth AmericaOfirmevPatentsPerrigo

Perrigo confirms ANDA filing for generic Astepro nasal spray


US generic drugmaker Perrigo (Nasdaq: PRGO;TASE) says that it has filed an Abbreviated New Drug Application…

AsteproAzelastine HydrochlorideGenericsImpax LaboratoriesLegalMedaNorth AmericaPatentsPerrigoRegulationRespiratory and Pulmonary

Watson picks up Perrigo generics as Paddock Labs buy closes; 2nd-qtr 2011 profits fall


US generics drugmaker Perrigo (Nasdaq: PRGO;TASE) say that it has closed its $540 million cash acquisition…

FinancialGenericsMergers & AcquisitionsPaddock LaboratoriesPerrigoWatson Pharmaceuticals

Back to top